Exablate Model 2100V1, Exablate Prostate System, Exablate MRgFUS, Exablate 2100V1 Type 3.0
510(k) K231378
Exablate (2100V1 +3 more) is a medical device (FDA Class II; FDA product code PLP, High Intensity Ultrasound System For Prostate Tissue Ablation) made by Insightec Ltd, cleared under FDA 510(k) K231378 on 30 Oct 2023, active as of 22 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK231378 | Date30 Oct 2023 | StatusActive |
Official records
- FDA 510(k) database K231378
From the FDA record
- Received by the FDA
- 12 May 2023
- FDA decision
- 30 Oct 2023 (Substantially Equivalent)
- FDA review time
- 171 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- PLP
- Models / Variants
- FDA applicant
- Insightec, Ltd.
- Device class
- Class II
- Regulation
- 21 CFR Part 876.4340
- Advisory committee
- Gastroenterology, Urology
- FDA decision
- SESE Substantially Equivalent
Similar devices
Other devices filed under FDA product code PLP (High Intensity Ultrasound System For Prostate Tissue Ablation).